A patient in London was being treated for cancer for about 18 months. Now he has been released from HIV and he has no longer been taking HIV drugs.
But the researchers still can’t give confirmation about the positive results of the treatment. They have been saying it’s too early to say the patient is “cured” completely of HIV.
Experts do believe that one day they will help find a cure for this virus.
While talking about the male patient of London, he was diagnosed with HIV in 2003. He further advanced with his treatment of Hodgkin’s lymphoma in 2012.
So, in the process of treating the patient with Hodgkin’s cancer, he also had chemotherapy. With regards to this, stem cells were implanted into the patient from a donor. The stem cells were said to be resistant to HIV, which could result in both his cancer and HIV going gradually into submission.
Many researchers from the University College of London with Imperial College of London along with Cambridge and Oxford Universities were all actively involved and intrigued by the case structure.
A patient treated in this way second time in a row resulted in cancellation of HIV.
Talking about another case of ten years ago, a patient in Berlin received a bone-marrow transplant. He received the transplant from a donor which provided him with a natural immunity to the virus.
The first person who is known to “beat” HIV/ Aids is Timothy Brown. He was given two transplants and total body irradiation (radiotherapy) for leukaemia. This was considered a much more vigorous treatment.
Prof Ravindra Gupta who is a lead author from UCL said “By achieving remission in a second patient using a similar approach, we have shown that the Berlin patient was not an anomaly and that it really was the treatment approaches that eliminated HIV in these two people.”
Another research expert named Prof Eduardo Olavarria from Imperial College London said this new success on experimentation of stem cell transplantation offered hope to the experts and they have been motivated to make new strategies which could be developed in order to tackle the virus.
The professor further added “The treatment is not appropriate as a standard HIV treatment because of the toxicity of chemotherapy, which in this case was required to treat the lymphoma.”